News Focus
News Focus
Followers 51
Posts 5124
Boards Moderated 0
Alias Born 03/23/2014

Re: Rkmatters post# 53806

Sunday, 02/14/2016 6:23:42 PM

Sunday, February 14, 2016 6:23:42 PM

Post# of 826069
Regarding that patent persuit, I did not recognize Revimmune (shown towards the top, together with COGNATE BIOSERVICES, INC. , NORTHWEST BIOTHERAPEUTICS , The Regents of the University of California ).

Revimmune (Trademark)... Paris, France.
Owner: Linda Powers.
trademark.markify.com/trademarks/ctm/revimmune/013303201


In International Class 5:
Biological and pharmaceutical preparations, namely biological and pharmaceutical preparations and substances for the prevention and treatment of blood disease and cancer, viral and other infectious diseases, and the modulation and treatment of immune system related diseases and disorders.
In International Class 42:
Research and development of biologicals and pharmaceuticals in the prevention and treatment of blood disease and cancer, viral and other infectious diseases, and the modulation and treatment of immune system related diseases and disorders.

OR:

Is this a different Revimmune?
"Cytheris changed its name to Revimmune SAS" (01 Jul 2015)
http://adisinsight.springer.com/drugs/800020133
related to Interleukin-7
such as:
https://clinicaltrials.gov/ct2/show/NCT02659800
IL-7 in Increasing Low CD4 Counts After Concurrent Radiation and Temozolomide Treatment in Patients With High Grade Gliomas
Sponsors and Collaborators:
Sidney Kimmel Comprehensive Cancer Center
National Cancer Institute (NCI)
Revimmune


The patent also mentioned "Ganjel; James Kelly"
Looks like he is with Toucan.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News